Cellular Defects and Altered Gene Expression in PC12 Cells Stably Expressing Mutant Huntingtin

Expanded polyglutamine tracts cause huntingtin and other proteins to accumulate and aggregate in neuronal nuclei. Whether the intranuclear aggregation or localization of a polyglutamine protein initiates cellular pathology remains controversial. We established stably transfected pheochromocytoma PC12 cells that express the N-terminal fragment of huntingtin containing 20 (20Q) or 150 (150Q) glutamine residues. The 150Q protein is predominantly present in the nuclei, whereas the 20Q protein is distributed throughout the cytoplasm. Electron microscopic examination confirmed that most of the 150Q protein is diffuse in the nucleus with very few microscopic aggregates observed. Compared with parental PC12 cells and cells expressing 20Q, cells expressing 150Q display abnormal morphology, lack normal neurite development, die more rapidly, and are more susceptible to apoptotic stimulation. The extent of these cellular defects in 150Q cells is correlated with the expression level of the 150Q protein. Differential display PCR and expression studies show that cells expressing 150Q have altered expression of multiple genes, including those that are important for neurite outgrowth. Our study suggests that mutant huntingtin in the nucleus is able to induce multiple cellular defects by interfering with gene expression even in the absence of aggregation.

[1]  Fumiaki Tanaka,et al.  Nuclear inclusions of the androgen receptor protein in spinal and bulbar muscular atrophy , 1998, Annals of neurology.

[2]  S. Rusconi,et al.  Transcriptional activation modulated by homopolymeric glutamine and proline stretches. , 1994, Science.

[3]  S. W. Davies,et al.  Exon 1 of the HD Gene with an Expanded CAG Repeat Is Sufficient to Cause a Progressive Neurological Phenotype in Transgenic Mice , 1996, Cell.

[4]  Steven Finkbeiner,et al.  Huntingtin Acts in the Nucleus to Induce Apoptosis but Death Does Not Correlate with the Formation of Intranuclear Inclusions , 1998, Cell.

[5]  M. Yanagida,et al.  Molecular Cloning and Cell Cycle-dependent Expression of Mammalian CRM1, a Protein Involved in Nuclear Export of Proteins* , 1997, The Journal of Biological Chemistry.

[6]  G. Lewin,et al.  Neurotrophins Live or Let Die: Does p75NTR Decide? , 1997, Neuron.

[7]  R. Yao,et al.  Specific Activation of a c-Jun NH2-terminal Kinase Isoform and Induction of Neurite Outgrowth in PC-12 Cells by Staurosporine* , 1997, The Journal of Biological Chemistry.

[8]  A. Hackam,et al.  Length of huntingtin and its polyglutamine tract influences localization and frequency of intracellular aggregates , 1998, Nature Genetics.

[9]  Mark Turmaine,et al.  Formation of Neuronal Intranuclear Inclusions Underlies the Neurological Dysfunction in Mice Transgenic for the HD Mutation , 1997, Cell.

[10]  S. Hersch,et al.  The Cellular and Subcellular Localization of Huntingtin-Associated Protein 1 (HAP1): Comparison with Huntingtin in Rat and Human , 1998, The Journal of Neuroscience.

[11]  S. Snyder,et al.  A huntingtin-associated protein enriched in brain with implications for pathology , 1995, Nature.

[12]  Michael A. Mancini,et al.  Chaperone suppression of aggregation and altered subcellular proteasome localization imply protein misfolding in SCA1 , 1998, Nature Genetics.

[13]  Nahida Matta,et al.  CAG expansion affects the expression of mutant huntingtin in the Huntington's disease brain , 1995, Neuron.

[14]  Harry T Orr,et al.  Ataxin-1 Nuclear Localization and Aggregation Role in Polyglutamine-Induced Disease in SCA1 Transgenic Mice , 1998, Cell.

[15]  R. Shigemoto,et al.  Localization of a metabotropic glutamate receptor, mGluR7, in axon terminals of presumed nociceptive, primary afferent fibers in the superficial layers of the spinal dorsal horn: an electron microscope study in the rat , 1997, Neuroscience Letters.

[16]  R. S. Williams,et al.  Evidence for neuronal degeneration and dendritic plasticity in cortical pyramidal neurons of Huntington's disease , 1993, Neurology.

[17]  C. Dargemont,et al.  Evidence for a role of CRM1 in signal-mediated nuclear protein export. , 1997, Science.

[18]  M. Chao Neurotrophin receptors: A window into neuronal differentiation , 1992, Neuron.

[19]  R. Tjian,et al.  Analysis of Sp1 in vivo reveals mutiple transcriptional domains, including a novel glutamine-rich activation motif , 1988, Cell.

[20]  G. Graveland,et al.  Evidence for degenerative and regenerative changes in neostriatal spiny neurons in Huntington's disease. , 1985, Science.

[21]  B. Birren,et al.  Rat metallothionein-1 structural gene and three pseudogenes, one of which contains 5'-regulatory sequences , 1986, Molecular and cellular biology.

[22]  R. Bradshaw,et al.  Staurosporine Causes Epidermal Growth Factor to Induce Differentiation in PC12 Cells via Receptor Up-regulation (*) , 1995, The Journal of Biological Chemistry.

[23]  R. Albin,et al.  Ectopically Expressed CAG Repeats Cause Intranuclear Inclusions and a Progressive Late Onset Neurological Phenotype in the Mouse , 1997, Cell.

[24]  Minoru Yoshida,et al.  CRM1 Is an Export Receptor for Leucine-Rich Nuclear Export Signals , 1997, Cell.

[25]  H. Green,et al.  Transglutaminase action imitates Huntington's disease: selective polymerization of Huntingtin containing expanded polyglutamine. , 1998, Molecular cell.

[26]  E. Shooter,et al.  The rat trk protooncogene product exhibits properties characteristic of the slow nerve growth factor receptor. , 1992, Proceedings of the National Academy of Sciences of the United States of America.

[27]  L. Gollapudi,et al.  Different mechanisms for inhibition of cell proliferation via cell cycle proteins in PC12 cells by nerve growth factor and staurosporine , 1997, Journal of neuroscience research.

[28]  L. Greene,et al.  Establishment of a noradrenergic clonal line of rat adrenal pheochromocytoma cells which respond to nerve growth factor. , 1976, Proceedings of the National Academy of Sciences of the United States of America.

[29]  Michael R. Hayden,et al.  The Influence of Huntingtin Protein Size on Nuclear Localization and Cellular Toxicity , 1998, The Journal of cell biology.

[30]  K. Moulder,et al.  Generation of Neuronal Intranuclear Inclusions by Polyglutamine-GFP: Analysis of Inclusion Clearance and Toxicity as a Function of Polyglutamine Length , 1999, The Journal of Neuroscience.

[31]  P. Bhide,et al.  Analysis of huntingtin‐associated protein 1 in mouse brain and immortalized striatal neurons , 1999, The Journal of comparative neurology.

[32]  S. W. Davies,et al.  Altered brain neurotransmitter receptors in transgenic mice expressing a portion of an abnormal human huntington disease gene. , 1998, Proceedings of the National Academy of Sciences of the United States of America.

[33]  Kohichi Tanaka Cloning and expression of a glutamate transporter from mouse brain , 1993, Neuroscience Letters.

[34]  Minoru Yoshida,et al.  CRM1 is responsible for intracellular transport mediated by the nuclear export signal , 1997, Nature.

[35]  P. Worley,et al.  Huntingtin-associated protein 1 (HAP1) interacts with the p150Glued subunit of dynactin. , 1997, Human molecular genetics.

[36]  J T Finch,et al.  Glutamine repeats as polar zippers: their possible role in inherited neurodegenerative diseases. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[37]  A. Tischler,et al.  Mimicry and Inhibition of Nerve Growth Factor Effects: Interactions of Staurosporine, Forskolin, and K252a in PC12 Cells and Normal Rat Chromaffin Cells In Vitro , 1990, Journal of neurochemistry.

[38]  M. MacDonald,et al.  Huntington's disease: translating a CAG repeat into a pathogenic mechanism , 1996, Current Opinion in Neurobiology.

[39]  A Dürr,et al.  Spinocerebellar ataxia type 7 (SCA7): a neurodegenerative disorder with neuronal intranuclear inclusions. , 1998, Human molecular genetics.

[40]  S. Hersch,et al.  A Human HAP1 Homologue , 1998, The Journal of Biological Chemistry.

[41]  Y. Wang,et al.  Leptomycin B is an inhibitor of nuclear export: inhibition of nucleo-cytoplasmic translocation of the human immunodeficiency virus type 1 (HIV-1) Rev protein and Rev-dependent mRNA. , 1997, Chemistry & biology.

[42]  N. Danbolt The high affinity uptake system for excitatory amino acids in the brain , 1994, Progress in Neurobiology.

[43]  A. Roses,et al.  Huntingtin and DRPLA proteins selectively interact with the enzyme GAPDH , 1996, Nature Medicine.

[44]  K. Fischbeck,et al.  Intranuclear Inclusions of Expanded Polyglutamine Protein in Spinocerebellar Ataxia Type 3 , 1997, Neuron.

[45]  D. Chuang,et al.  Nuclear Translocation of Glyceraldehyde‐3‐Phosphate Dehydrogenase Isoforms During Neuronal Apoptosis , 1999, Journal of neurochemistry.

[46]  D. Choi,et al.  Staurosporine-Induced Neuronal Apoptosis , 1995, Experimental Neurology.

[47]  J. Lancaster,et al.  Metallothionein protects against the cytotoxic and DNA-damaging effects of nitric oxide. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[48]  S. W. Davies,et al.  Intranuclear Neuronal Inclusions in Huntington's Disease and Dentatorubral and Pallidoluysian Atrophy: Correlation between the Density of Inclusions andIT15CAG Triplet Repeat Length , 1998, Neurobiology of Disease.

[49]  S. W. Davies,et al.  Aggregation of huntingtin in neuronal intranuclear inclusions and dystrophic neurites in brain. , 1997, Science.

[50]  Shihua Li,et al.  Aggregation of N-terminal huntingtin is dependent on the length of its glutamine repeats. , 1998, Human molecular genetics.

[51]  D. Housman,et al.  The complex pathology of trinucleotide repeats. , 1997, Current opinion in cell biology.

[52]  A. Tischler,et al.  A protein kinase inhibitor, staurosporine, mimics nerve growth factor induction of neurotensin/neuromedin N gene expression. , 1991, The Journal of biological chemistry.

[53]  H. Zoghbi,et al.  The cerebellar leucine-rich acidic nuclear protein interacts with ataxin-1 , 1997, Nature.

[54]  S. Hersch,et al.  Interaction of Huntingtin-Associated Protein with Dynactin P150Glued , 1998, The Journal of Neuroscience.

[55]  S. Tsuji,et al.  Suppression of aggregate formation and apoptosis by transglutaminase inhibitors in cells expressing truncated DRPLA protein with an expanded polyglutamine stretch , 1998, Nature Genetics.

[56]  H. Zoghbi,et al.  Erratum: Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures , 1998, Nature.

[57]  C A Ross,et al.  Truncated N-terminal fragments of huntingtin with expanded glutamine repeats form nuclear and cytoplasmic aggregates in cell culture. , 1998, Human molecular genetics.

[58]  H. Paulson,et al.  Evidence for proteasome involvement in polyglutamine disease: localization to nuclear inclusions in SCA3/MJD and suppression of polyglutamine aggregation in vitro. , 1999, Human molecular genetics.

[59]  H. Lehrach,et al.  SH3GL3 associates with the Huntingtin exon 1 protein and promotes the formation of polygln-containing protein aggregates. , 1998, Molecular cell.

[60]  H. Lehrach,et al.  Ataxin-3 is transported into the nucleus and associates with the nuclear matrix. , 1998, Human molecular genetics.

[61]  G. Guroff,et al.  Nerve growth factor-induced alteration in the response of PC12 pheochromocytoma cells to epidermal growth factor , 1981, The Journal of cell biology.

[62]  M. Karin Metallothioneins: Proteins in search of function , 1985, Cell.

[63]  D. Chuang,et al.  Nuclear localization of overexpressed glyceraldehyde-3-phosphate dehydrogenase in cultured cerebellar neurons undergoing apoptosis. , 1998, Molecular pharmacology.

[64]  R. Burry,et al.  Neuronotypic Differentiation Results in Reduced Levels and Altered Distribution of Synaptophysin in PC 12 Cells , 1993, Journal of neurochemistry.

[65]  C A Ross,et al.  Intranuclear Neuronal Inclusions: A Common Pathogenic Mechanism for Glutamine-Repeat Neurodegenerative Diseases? , 1997, Neuron.

[66]  J. B. Martin,et al.  Selective sparing of a class of striatal neurons in Huntington's disease. , 1985, Science.

[67]  A. Hackam,et al.  In vitro evidence for both the nucleus and cytoplasm as subcellular sites of pathogenesis in Huntington's disease. , 1999, Human molecular genetics.

[68]  T. Kao,et al.  Isolation and characterization of rat and human glyceraldehyde-3-phosphate dehydrogenase cDNAs: genomic complexity and molecular evolution of the gene. , 1985, Nucleic acids research.

[69]  K. Fischbeck,et al.  Spinocerebellar ataxia type-1 and spinobulbar muscular atrophy gene products interact with glyceraldehyde-3-phosphate dehydrogenase. , 1996, Human molecular genetics.

[70]  Y. Agid,et al.  Polyglutamine expansion as a pathological epitope in Huntington's disease and four dominant cerebellar ataxias , 1995, Nature.

[71]  H. Zoghbi,et al.  Ataxin-1 with an expanded glutamine tract alters nuclear matrix-associated structures , 1997, Nature.

[72]  Claire-Anne Gutekunst,et al.  Nuclear and Neuropil Aggregates in Huntington’s Disease: Relationship to Neuropathology , 1999, The Journal of Neuroscience.

[73]  S. Snyder,et al.  Glyceraldehyde-3-phosphate dehydrogenase: nuclear translocation participates in neuronal and nonneuronal cell death. , 1997, Proceedings of the National Academy of Sciences of the United States of America.

[74]  R. Tjian,et al.  Synergistic activation by the glutamine-rich domains of human transcription factor Sp1 , 1989, Cell.

[75]  J. Comella,et al.  Characterization of the Cell Death Process Induced by Staurosporine in Human Neuroblastoma Cell Lines , 1997, Neuropharmacology.

[76]  E. Shooter,et al.  Gene transfer and molecular cloning of the rat nerve growth factor receptor , 1987, Nature.